Zurcher Kantonalbank (Zurich Cantonalbank) Regeneron Pharmaceuticals, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 139,749 shares of REGN stock, worth $103 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

139,749

Previous 139,749 -0.0%

Holding current value

$103 Million

Previous $147 Million -0.0%

% of portfolio

0.45%

Previous 0.45%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$1024.09 - $1201.76 $5.24 Million - $6.15 Million	-5,116 Reduced 3.53%	139,749 $147 Million
Q2 2024 Jul 29, 2024	BUY	$883.2 - $1071.19 $59.4 Million - $72 Million	67,235 Added 86.61%	144,865 $152 Million
Q1 2024 Apr 25, 2024	BUY	$902.69 - $993.35 $10.5 Million - $11.6 Million	11,670 Added 17.69%	77,630 $74.7 Million
Q4 2023 Jan 30, 2024	BUY	$775.18 - $881.7 $427,899 - $486,698	552 Added 0.84%	65,960 $57.9 Million
Q3 2023 Oct 25, 2023	BUY	$692.45 - $844.37 $1.68 Million - $2.05 Million	2,427 Added 3.85%	65,408 $53.8 Million
Q2 2023 Aug 07, 2023	BUY	$700.03 - $830.35 $2.09 Million - $2.48 Million	2,991 Added 4.99%	62,981 $45.3 Million
Q1 2023 May 08, 2023	BUY	$680.49 - $826.97 $12.8 Million - $15.5 Million	18,775 Added 45.55%	59,990 $49.3 Million
Q4 2022 Feb 01, 2023	BUY	$705.89 - $766.39 $5.1 Million - $5.53 Million	7,222 Added 21.25%	41,215 $29.7 Million
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $312,239 - $394,030	544 Added 1.63%	33,993 $23.4 Million
Q2 2022 Aug 09, 2022	SELL	$548.35 - $738.84 $4.37 Million - $5.88 Million	-7,964 Reduced 19.23%	33,449 $19.8 Million
Q1 2022 Apr 21, 2022	BUY	$595.12 - $698.43 $4.2 Million - $4.93 Million	7,063 Added 20.56%	41,413 $28.9 Million
Q4 2021 Feb 01, 2022	SELL	$543.48 - $670.97 $8.7 Million - $10.7 Million	-16,003 Reduced 31.78%	34,350 $21.7 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $5.87 Million - $6.97 Million	-10,234 Reduced 16.89%	50,353 $30.5 Million
Q2 2021 Jul 30, 2021	BUY	$472.8 - $558.54 $3.85 Million - $4.54 Million	8,133 Added 15.51%	60,587 $33.8 Million
Q1 2021 May 03, 2021	BUY	$446.73 - $548.2 $2.75 Million - $3.37 Million	6,150 Added 13.28%	52,454 $24.8 Million
Q4 2020 Jan 28, 2021	BUY	$478.3 - $607.98 $4.14 Million - $5.26 Million	8,651 Added 22.98%	46,304 $22.4 Million
Q3 2020 Nov 06, 2020	BUY	$544.75 - $658.21 $2.63 Million - $3.18 Million	4,825 Added 14.7%	37,653 $21.1 Million
Q2 2020 Jul 28, 2020	SELL	$493.32 - $643.92 $2.61 Million - $3.41 Million	-5,292 Reduced 13.88%	32,828 $20.5 Million
Q1 2020 May 06, 2020	BUY	$336.18 - $494.43 $6.05 Million - $8.9 Million	17,992 Added 89.39%	38,120 $18.6 Million
Q4 2019 Jan 21, 2020	BUY	$274.13 - $376.51 $158,173 - $217,246	577 Added 2.95%	20,128 $7.56 Million
Q3 2019 Oct 18, 2019	BUY	$273.46 - $318.39 $69,458 - $80,871	254 Added 1.32%	19,551 $5.42 Million
Q2 2019 Jul 30, 2019	SELL	$299.6 - $414.82 $526,696 - $729,253	-1,758 Reduced 8.35%	19,297 $6.04 Million
Q1 2019 Apr 29, 2019	BUY	$372.08 - $439.57 $1 Million - $1.19 Million	2,698 Added 14.7%	21,055 $8.65 Million
Q4 2018 Jan 25, 2019	BUY	$335.82 - $403.04 $1.12 Million - $1.35 Million	3,349 Added 22.31%	18,357 $6.86 Million
Q3 2018 Nov 09, 2018	SELL	$351.14 - $408.51 $161,173 - $187,506	-459 Reduced 2.97%	15,008 $6.06 Million
Q2 2018 Aug 06, 2018	BUY	$284.6 - $344.99 $179,298 - $217,343	630 Added 4.25%	15,467 $5.34 Million
Q4 2017 Jan 31, 2018	SELL	$358.63 - $469.95 $1.12 Million - $1.46 Million	-3,117 Reduced 17.36%	14,837 $5.58 Million
Q3 2017 Nov 08, 2017	BUY	$431.38 - $504.0 $7.74 Million - $9.05 Million	17,954	17,954 $8.03 Million

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Regeneron Pharmaceuticals, Inc. Transaction History